← Leaderboards
Shruti Sharma
Augusta University
$2,813,202
Attributed
$3,336,404
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $915K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,336,404 · 3
By mechanism
R01$3,336,404 · 3
Top collaborators
- Ashok Sharma2 shared
Most similar at Augusta University
Same institution · by research overlap
- Ruth B. Caldwell$11,181,117
- Ashok Sharma$2,034,790
- Modesto Antonio Rojas$593,863
- Manuela Bartoli$4,552,283
Others in their field
Top investigators on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Edward W Maly · United Nations Children'S Fund$264,005,699
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
VisionPlayPathologyNovel Therapeutic InterventionMembranePathogenesisDiabetic MouseBindingEndotheliumInflammatoryInterleukin 6 ReceptorInterleukin-6In VivoMediatingAmericanCytokineDiabetes MellitusBlood VesselsDiabetic RetinopathyEndothelial CellsBlindnessInflammationCharacteristicsInjury
Grant awards (8)
Sex-specific Influences on tear microRNAs in dry eye disease$516,391
R01 · FY2025 · EY
Targeting Interleukin-6 cis-trans balance in Müller cell dysfunction$385,000
R01 · FY2025 · EY · contact PI
Sex-specific Influences on tear microRNAs in dry eye disease$530,013
R01 · FY2024 · EY
Targeting Interleukin-6 cis-trans balance in Müller cell dysfunction$385,000
R01 · FY2024 · EY · contact PI
Targeting Interleukin-6 Trans-signaling in Diabetic Retinopathy$380,000
R01 · FY2019 · EY · contact PI
Targeting Interleukin-6 Trans-signaling in Diabetic Retinopathy$380,000
R01 · FY2018 · EY · contact PI
Targeting Interleukin-6 Trans-signaling in Diabetic Retinopathy$380,000
R01 · FY2017 · EY · contact PI
Targeting Interleukin-6 Trans-signaling in Diabetic Retinopathy$380,000
R01 · FY2016 · EY · contact PI